Advertisement

Clinical Implications

  • Ioannis K. Danielides
  • Antonis N. Nikolopoulos
Chapter

Abstract

Therapeutic decisions and clinical outcome of all different types of esophageal and gastric cancers depend largely on staging of the disease.

References

  1. 1.
    AJCC (2010) AJCC cancer staging manual, 7th edn. Springer, New York, NYGoogle Scholar
  2. 2.
    Ajani JA, In H, Sano T et al (2017) AJCC cancer staging manual, 8th Amin MB (edn) edn. AJCC, Chicago, p 203CrossRefGoogle Scholar
  3. 3.
    Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57:1200–1206CrossRefGoogle Scholar
  4. 4.
    Van Westreenen HL, Heeren PA, van Dullemen HM et al (2005) Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 9:54–61CrossRefGoogle Scholar
  5. 5.
    Kim SJ, Kim HH, Kim YH et al (2009) Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology 253:407–415CrossRefGoogle Scholar
  6. 6.
    Pollack BJ, Chak A, Sivak MV Jr (1996) Endoscopic ultrasonography. Semin Oncol 23:336–346PubMedGoogle Scholar
  7. 7.
    Lowy AM, Mansfield PF, Leach SD et al (1996) Laparoscopic staging for gastric cancer. Surgery 119:611–614CrossRefGoogle Scholar
  8. 8.
    Hiki Y, Shimao H, Mieno H et al (1995) Modified treatment of early gastric cancer: evaluation of endoscopic treatment of early gastric cancers with respect to treatment indication groups. World J Surg 19:517–522CrossRefGoogle Scholar
  9. 9.
    Fukase K, Kato M, Kikuchi S et al (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Japan Gast Study Group Lancet 372:392–397Google Scholar
  10. 10.
    Bayerdörffer E, Neubauer A, Rudolph B et al (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345:1591–1594CrossRefGoogle Scholar
  11. 11.
    Ye H, Liu H, Raderer MI et al (2003) High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 101:2547–2550CrossRefGoogle Scholar
  12. 12.
    Tomita N, Kodaira T, Tachibana H et al (2009) Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma. Radiother Oncol 90:231–235CrossRefGoogle Scholar
  13. 13.
    Fletcher CD, Berman JJ, Corless C et al (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465CrossRefGoogle Scholar
  14. 14.
    Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stro mal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long- term follow-up. Am J Surg Pathol 29:52–68CrossRefGoogle Scholar
  15. 15.
    Tio TL, Tytgat GN, den Hartog Jager FC (1990) Endoscopic ultrasonography for the evaluation of smooth muscle tumors in the upper gastrointestinal tract: an experience with 42 cases. Gastrointest Endosc 36:342–350CrossRefGoogle Scholar
  16. 16.
    Blanke CD, Demetri GD, Metal v M (2008) Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oneal 26:620–625CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Ioannis K. Danielides
    • 1
  • Antonis N. Nikolopoulos
    • 1
  1. 1.Gastroenterology DepartmentHygeia HospitalAthensGreece

Personalised recommendations